Percentages of CD3−/lo and CD3in/hi Cells Among CD4/CD8 Subpopulations at Different Days P-Ir
| CD3 . | CD4+ . | DP . | DN . | CD8+ . | ||||
|---|---|---|---|---|---|---|---|---|
| −/lo . | in/hi . | −/lo . | in/hi . | −/lo . | in/hi . | −/lo . | in/hi . | |
| Control | 6.1 | 93.9 | 88.6 | 11.4 | 81.8 | 18.2 | 46.9 | 53.1 |
| Day 1 P-ir | 3.2 | 96.8 | 65.7 | 34.3 | 59.7 | 40.3 | 3.9 | 96.1 |
| Day 2 P-ir | 1.1 | 98.9 | 65.4 | 34.6 | 61.9 | 38.1 | 1.7 | 98.3 |
| Day 3 P-ir | 4.1 | 95.9 | 74.4 | 25.6 | 85.3 | 14.7 | 47.6 | 52.4 |
| Day 4 P-ir | 33.7 | 66.3 | 93.4 | 6.4 | 87.9 | 12.1 | 83.2 | 16.8 |
| Day 5 P-ir | 36.3 | 63.7 | 94.9 | 5.1 | 86.1 | 13.9 | 71.0 | 29.0 |
| Day 7 P-ir | 28.6 | 71.4 | 91.6 | 8.4 | 84.9 | 15.1 | 82.9 | 17.1 |
| Day 10 P-ir | 10.7 | 89.3 | 87.0 | 13.0 | 70.6 | 29.4 | 57.8 | 42.2 |
| CD3 . | CD4+ . | DP . | DN . | CD8+ . | ||||
|---|---|---|---|---|---|---|---|---|
| −/lo . | in/hi . | −/lo . | in/hi . | −/lo . | in/hi . | −/lo . | in/hi . | |
| Control | 6.1 | 93.9 | 88.6 | 11.4 | 81.8 | 18.2 | 46.9 | 53.1 |
| Day 1 P-ir | 3.2 | 96.8 | 65.7 | 34.3 | 59.7 | 40.3 | 3.9 | 96.1 |
| Day 2 P-ir | 1.1 | 98.9 | 65.4 | 34.6 | 61.9 | 38.1 | 1.7 | 98.3 |
| Day 3 P-ir | 4.1 | 95.9 | 74.4 | 25.6 | 85.3 | 14.7 | 47.6 | 52.4 |
| Day 4 P-ir | 33.7 | 66.3 | 93.4 | 6.4 | 87.9 | 12.1 | 83.2 | 16.8 |
| Day 5 P-ir | 36.3 | 63.7 | 94.9 | 5.1 | 86.1 | 13.9 | 71.0 | 29.0 |
| Day 7 P-ir | 28.6 | 71.4 | 91.6 | 8.4 | 84.9 | 15.1 | 82.9 | 17.1 |
| Day 10 P-ir | 10.7 | 89.3 | 87.0 | 13.0 | 70.6 | 29.4 | 57.8 | 42.2 |
Data obtained with thymocyte pools from 3 to 9 mice.